Exciva raises €9.0M Series A round
26 October 2021· Heidelberg, Germany· health, neuroscience, biotech, b2b, deep_hardware
The company intends to use the funds to develop its lead candidate, Deraphan, up to the completion of Phase I clinical trials.
Investors
LeadAndera Partners
Also participating
LBBW Venture CapitalCure8
About Exciva
Stage
Series B
Headquarters
Heidelberg, Germany
Founded
2016
Team Size
6–20
Sectors
healthneurosciencebiotechb2bdeep_hardware
Source: https://www.finsmes.com/2021/10/exciva-raises-e9m-in-series-a-funding.html